Inflammation as the cause of the metabolic syndrome in depression

Modern Trends in Pharmacopsychiatry

Volumn 28, Issue , 2013, Pages 117-126

  Leonard, Brian E ^a,b,c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; HYDROCORTISONE;

ARTICLE; COMORBIDITY; DEPRESSION; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HYGIENE; HYPERCORTISOLISM; ILLNESS BEHAVIOR; IMMUNE SYSTEM; INFLAMMATION; LIFESTYLE; METABOLIC SYNDROME X; PERSONAL EXPERIENCE; PRIORITY JOURNAL; STRESS; ANIMAL; BLOOD; COMPLICATION; ETIOLOGY; IMMUNOLOGY; MENTAL HEALTH; MENTAL STRESS; PATHOLOGY; PSYCHOLOGY;

ANIMALS; DEPRESSION; HUMANS; HYDROCORTISONE; IMMUNE SYSTEM; INFLAMMATION; MENTAL HEALTH; METABOLIC SYNDROME X; STRESS, PSYCHOLOGICAL;

EID: 84880772193     PISSN: 16622685     EISSN: 16624505     Source Type: Book Series    
DOI: 10.1159/000343974     Document Type: Article

References (56)

1. Frasure-Smith N, Lesperance F, Talajic MD: Depression and 18 month prognosis of myocardial infarction. Circulation 1995;91:999-1005
2. Anisman H, Merali Z: Cytokines, stress and depressive illness: Brain-immune interactions. Ann Med 2003;35:2-11
3. Dantzer R, Capuron L, Irwin M, et al: Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology 2008;33:18-29
4. Heiskanen TH, Niskanen LK, Hintikka JJ, et al: Metabolic syndrome and depression: A cross sectional analysis. J Clin Psychiatry 2006;67:1422-1427
5. Irwin MR, Cole SW: Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 2011;11: 625-632
6. Dantzer R, O'Connor JC, Freund GG, et al: From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-57
7. Hart BL: Biological basis of the behaviour of sick animals. Neurosci Biobehav Rev 1988;12:1232-1237
8. Haroon E, Raison CL, Miller AH: Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior. Neuropsychopharmacol Rev 2012;37:137-162
9. Frank MG, Barattar MV, Springer DB, et al: Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS proinflammatory cytokine responses. Brain Behav Immunol 2007;21:47-59
10. Bluthe RM, Walter V, Parnet P, et al: Lipopolysaccharide induces sickness behaviour in rats by vagal mediated mechanism. C R Acad Sci 1994;111:499-503
11. Capuron L, Gumnick JF, Musselman DL, et al: Neurobehavioural effects of interferon alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacoology 2002;26:643-652
12. Raison CL, Borisov AS, Majer M, et al: Activation of CNS inflammatory pathways by interferon alpha: Relationship to monoamines and depression. Biol Psychiatry 2007;65:296-307
13. Maes M, Berk M, Song C, et al: Major depression, a progressive disorder and sickness behaviour. Submitted, 2012
14. Janszky I, Lekander M, Blom M, et al: Self-rated health and vital exhaustion, but not depression,is related to inflammation in women with coronary heart disease. Brain Behav Immunol 2005;19: 555-563
15. Besedovsky HO, delRey A: Immuneneuro-endocrine interactions: Facts and hypothesis. Endocr Rev 1996;17:64-102
16. Pariante CM, Pearce BD, Pisell TL, et al: The proinflammatory cytokine, interleukin 1 alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1997;140:4359-4366
17. Gold PW, Chrousos GP: Organisation of the stress system and its dysregulation in melancholic and atypical depression: High verses low CRH/ NE states. Mol Psychiatry 2002;7:254-275
18. von Mutius E: Allergies, infections and the hygiene hypothesis: The epidemiological evidence. Immunobiology 2007;212:435-439
19. Panina-Bordignan P: Beta-2 agonists prevent Th-1 development by selective inhibition of IL-12. J Clin Invest 1997; 100:1513-1519
20. Das UN: Obesity, metabolic syndrome X and inflammation. Nutrition 2002;18: 430-438
21. Farmer A, Korszun A, Owen MJ, et al: Medical disorders in people with recurrent depression. Br J Psychiatr 2008;192: 351-355
22. Irwin MR, Cole SW: Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 2011;11: 625-632
23. Pariante CM, Lighman SL: The HPA axis in major depression: Classic theories and new developments. Trends Neurosci 2008;31:464-468
24. Christian LM, Glaser R, Porter K, et al: Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology 2011;36:1495-1504
25. Pariante CM, Miller AH: Glucocorticoid receptors in major depressionrelevance to pathophysiology and treatment. Biol Psychiatr 2001;49:391-404
26. Black PH: The inflammatory consequences of psychological stress: Relationship to insulin resistance, atherosclerosis and diabetes mellitus, type-2. Med Hypoth 2006;67:879-891
27. Victor W, Vieweg R, Pandurangi AK: Editorial: The relation of stress and psychiatric illness to coronary heart disease. Acta Psychiatr Scand 2006;113:241-244
28. Das UN: Is type 2 diabetes mellitus a disorder of the braiñ Nutrition 2002;18: 667-672
29. Davidson KW, Schwartz JE, Kirkland SA, et al: Relation of inflammation to depression and coronary heart disease (from the Canadian Nova Scotia Health Survey Prospective population study). Am J Cardiol 2009;103:755-761
30. Miller AH, Maletic V, Raison CL: Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatr 2009; 65:732-741
31. Danese A, Pariante CM, Caspi A, et al: Childhood maltreatment predicts adult inflammation in a life-course study. PNAS 2007;104:1319-1324
32. Danese A, Moffitt TZ, Pariante CM, et al: Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatr 2008;65:4405-4015
33. Besedovsky H, del Rey A, Sorkin F, Dinarello CA: Immunoregulatory feedback between IL-1 and glucocorticoid hormones. Science 1986;233:652-654
34. Ershler WB, Keller E: Age associated increased IL-6 gene expression, late life diseases and frailty. Ann Rev Med 2000;51:245-270
35. Hamerman D, Berman JW, Albers GW, et al: Emerging evidence for inflammation in conditions frequently affects older adults: Report of a symposium. J Am Geriatr Soc 1999;47:1016-1025
36. Borovikova LV, Ivanova S, Zhang M, et al: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458
37. Christian LM, Glaser R, Porter K, et al: Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology 2011;36:1495-1504
38. Dantzer R: Cytokine-induced sickness behaviour: Mechanisms and implications. Ann NY Acad Sci 2001;933:222-234
39. Das UN: Is obesity an inflammatory conditioñ Nutrition 2001;17:953-966
40. Kelcolt-Glaser JK: Stress, food and inflammation: Psychoneuroimmunology and nutrition at the cutting edge. Psychosom Med 2010;72:365-369
41. Cunnane SC, McAdoo KR, Horrobin DF: N-3 essential fatty acids decrease weight gain in genetically obese mice. Br J Nutr 2986;56:87-91
42. Grebe KM: Cutting edge: Sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis. J Immunol 2009;184:540-544
43. Nanee DM, Sandersw VM: Autoimmune innervation and regulation of the immune system (1987-2007). Brain Behav Immunol 2007;21:736-745
44. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006;444: 860-867
45. Muenzberg H: Differential leptin access into the brain: A hierarchical organization of hypothalamic leptin target sites? Physiol Behav 2008;94:664-669
46. Martel P, Fantino M: Mesolimbic dopaminergic system activity as a function of food reward:A microdialysis study. Pharmacol Biochem Behav 1996;53:221-226
47. Willis T: Diabetes: A Medical Odyssey. New York, Tuckahoe, 1971
48. Lustman PJ, Clouse RE: Depression in diabetic patients: The relationship between mood and glycaemic control. J Diab Compl 2005;19:113-122
49. Lustman PJ, Anderson PJ, Freedland KE, et al: Depression and poor glycaemic control: A meta analytic review of the literature. Diabetes Care 2000;23:934-942
50. Lustman PJ, Anderson P, Freedland KE, et al: Depression and poor glycaemic control: A meta analytic review of the literature. Semin Clin Neuropsychiatr 1998;3:102-114
51. Geerlings MI, Schoevers RA, Beckman, et al: Depression and the risk of cognitive decline and Alzheimer's disease. Results of two prospective community based studies in the Netherlands. Br J Psychiatr 2000;176:556-575
52. Bezzi P, Domercq M, Brambilla L, et al: CXCR4 -Activated astrocyte glutamate release via TNF-Alpha: Amplification of microglia triggers neurotoxicity. Nat Neurosci 2001;4:702-710
53. Dantzer R, O'Connor JC, Freund GG, et al: From inflammation to sickness and depression when the immune system subjugates the brain. Nature Rev Neurosci 2008;9:46-57
54. Myint A-M, Kim Y-K, Verkerk R, et al: Kynurenine pathway in major depression: Evidence of impaired neuroprotection. J Affect Dis 2007;98:143-151
55. Schwarcz RT: The kynurenine pathway of tryptophan degradation as a drug target. Curr Opin Pharmacol 2004;4:12-17
56. Leonard BE, Myint A-M: Inflammation and depression: Is there a causal relationship with dementiä Neurotox Res 2006;10:149-160